Remap Consulting is a specialist pharmaceutical pricing and market access consultancy
We work with people responsible for the pricing and reimbursement of products who are asking:
What is the optimal price for our product?
Have we got the right evidence to support pricing and market access at launch?
Do we have the right training capabilities in house to secure pricing and reimbursement?
What is the pricing and market access potential for our business development opportunities?
Launch
Implementation
Price & Market Access Training
Price
Optimization
We now offer the NICE META tool as part of our Launch service
Our mission is to support you in solving your pricing and market access challenges to improve patient access to your products
This has been an excellent two days. You have truly been a pleasure to work with, bringing great learning techniques as well as pricing and market access insights.
Excellent work. The project ran very smoothly and we appreciated your efficient approach to managing the project and delivery of final recommendations.
Latest News
How is COVID-19 impacting payers and HTA decisions across the EU? What are the implications for patient access for new pharmaceutical products?
Given the unprecedented global shutdown occurring in response to COVID-19, payers and HTA bodies are struggling to adjust to the [...]
NICE postpones majority of technology appraisals due to Covid-19
NICE have recently confirmed that during this time they will be prioritising and only publishing work that is either therapeutically [...]
What is a Payer?
In health care, the term ‘Payer’ generally refers to people or bodies other than the patient that finance or refund [...]
Graham guest lecturing at Manchester University tomorrow
Graham Foxon will be guest lecturing at Manchester University to Masters students on the topic of: 'Pricing and Market Access [...]